If Boostrix is given to an adult, rather than Adacel, should an adverse event report be submitted and does the patient need to be revaccinated?
Boostrix is not approved for use in persons 19 years of age or older. Although no safety and efficacy data are available, there is no reason to think that the vaccine would not be effective. Therefore, we would not recommend revaccination if a dose is administered to someone older than 18. We do recommend that a Vaccine Adverse Event Report (VAERS) report be completed for any administration error and we recommend that office procedures be reviewed to avoid a repeat occurrence.
